All blogs tagged FAQs
Alumni Ventures’ AML & KYC Regulatory RequirementsThe U.S. imposes various regulatory requirements on financial institutions and entities participating in the transfers of money as part of their businesses. As an investment advisor, Alumni Ventures is required to have anti-money laundering (“AML”) and know your customer (“KYC”) programs so that we do not facilitate money laundering — and can demonstrate that we have taken appropriate steps in that regard, including confirmation of customer identity.
VC 101: What’s the Difference Between Private Equity and Venture Capital?AV Co-Founder Luke Antal’s VC 101 video series provides insights on venture capital essentials. In this episode, the AV Chief Community Officer considers the difference between two key alternative asset classes: venture capital and private equity.
A Closer Look at Our Popular Deep Tech FundDeep Tech investments are startups combining science and engineering to tackle the toughest and potentially most lucrative technical challenges facing the world. Companies in the deep tech space offer innovative and disruptive products with the possibility to reshape entire sectors and verticals — a key reason why one in five unicorns is a deep tech company.
5 Reasons to Consider Making Venture Capital Part of Your Financial LegacyWhen people are asked what they’ll pass along to the next generation, the first things that come to mind are likely physical objects such as heirlooms, properties, or classic cars. But a truly impactful financial legacy bestows value far beyond what a piece of personal property can typically yield.
A Look Inside AV’s Blockchain FundBlockchain-based technologies offer unparalleled transparency, immutability, and security across a wide variety of industries, sectors, and applications. Innovative companies are utilizing this revolutionary technology to redefine the internet with a focus on digital ownership. Recent investment trends have made blockchain one of the most active sectors of private equity investments. The global blockchain market, which is divided into blockchain platforms and Blockchain-as-a-Service (BaaS), is projected to reach $69 billion in 2027. The tech’s application in existing industries is also a strong draw for investors. A Deloitte survey found that 86% of senior tech executives say that blockchain offers a compelling business case for their company. Gartner projects that businesses will gain $360 billion in value by 2026 thanks to blockchain-based projects — rising to $3.1 trillion by 2030. Alumni Ventures’ Blockchain Fund 3 will tap into this thriving ecosystem to identify and source high-potential blockchain opportunities for our investors. To learn more about how AV’s Blockchain Fund operates, we spoke with Alumni Ventures’ Chief Investment Officer Anton Simunovic.
AV’s Healthtech Fund ExplainedHealthtech represents one of the fastest-growing segments in healthcare. Emerging technologies such as bioprinting, genomics, and smart devices are driving revolutionary advances in healthcare while presenting valuable investment opportunities. Some sources gauge the global market size at ~$350 billion in 2019 and project growth to reach $950 billion by 2027. The venture story is, not surprisingly, equally robust. There are ~20,000 healthtech startups in the U.S., and VCs invested about $14 billion into the sector in 2020 — double 2019’s total. Some of this growth is due to the fact that consumers are increasingly embracing proactive, preventative, and personalized care, as well as self-monitoring products. Additionally, high healthcare costs are also increasing the demand for disruptive solutions. The global pandemic and the emergence of chronic diseases are also spurring innovation in telehealth and biotech. Alumni Ventures’ Healthtech Fund will target this intersection of entrepreneurship, growing trends, and transformative medical advances to source high-potential opportunities for investors. We spoke with Alumni Ventures’ Chief Investment Officer Anton Simunovic about what investors can expect from AV’s Healthtech Fund.
An In-Depth Look at Alumni Ventures’ Impact FundFor many investors, venture capital is about pursuing investments that will provide outsized returns AND align their portfolios with their values or beliefs. Savvy investors know helping entrepreneurs bring about positive change in the world is not mutually exclusive with making smart investments. Many lucrative opportunities exist in spaces where underrepresented entrepreneurs are aiming to solve some of the world’s most pressing issues. It’s this thesis that drives Alumni Ventures’ Impact Fund — doing well and doing good. For an in-depth explanation of the fund and its outlook, we spoke with Alumni Ventures’ Chief Investment Officer Anton Simunovic.
Exploring Alumni Ventures’ AI FundOver the past decade, artificial intelligence and machine learning have rapidly become some of the most important — and lucrative — modern advancements in technology. From autonomous driving to natural language processing and predictive modeling, AI has become a crucial component of emerging technologies that are reshaping many industries and sectors. Demand for innovative AI tech is continuing to grow rapidly, with the global market value projected to reach nearly $300 billion by 2026. Alumni Ventures’ AI Fund is dedicated to AI and machine learning opportunities that have the potential to provide lucrative returns and redefine the boundaries of what’s possible with AI. We discussed our AI Fund, its thesis, and its outlook with Chief Investment Officer Anton Simunovic.